Also found in: Wikipedia.


a chemoprotectant used to prevent renal toxicity in cisplatin chemotherapy and to reduce esophagitis, xerostomia, and loss of taste in patients receiving radiation therapy for head, neck, or lung cancer.



Pharmacologic class: Organic thiophosphate cytoprotective drug

Therapeutic class: Cytoprotectant

Pregnancy risk category C


Undergoes conversion to free thiol, an active metabolite that reduces toxic effects of cisplatin on renal tissue


Powder for injection: 500-mg anhydrous base and 500 mg mannitol in 10-ml vials

Indications and dosages

To reduce cumulative renal toxicity of cisplatin therapy in patients with ovarian cancer or non-small-cell lung

Adults: 910 mg/m2 I.V. daily as a 15-minute infusion, starting 30 minutes before chemotherapy

To reduce moderate to severe xerostomia in patients undergoing postoperative radiation treatment for head or neck cancer

Adults: 200 mg/m2 I.V. daily as a 3-minute infusion, starting 15 to 30 minutes before standard fraction radiation therapy

Off-label uses

• Protection against cisplatin- and paclitaxel-induced neurotoxicity


• Hypersensitivity to drug

• Hypotension


Use cautiously in:

• arrhythmias, heart failure, ischemic heart disease, renal impairment, hearing impairment, hypocalcemia, myasthenia gravis, nausea, vomiting, hypotension, obesity

• history of cerebrovascular accident or transient ischemic attacks

• concurrent antihypertensive therapy that can't be discontinued for 24 hours before amifostine therapy (not recommended)

• definitive radiotherapy (not recommended)

• elderly patients

• pregnant patients (safety and efficacy not established)

• breastfeeding patients

• children (safety and efficacy not established).


• Ensure that patient is adequately hydrated before starting drug.

• Give antiemetics before and during therapy.

• Reconstitute single-dose vial with 9.7 ml of sterile normal saline injection. May be further diluted with normal saline solution up to a concentration of 40 mg/ml.

• Don't mix with other drugs or solutions.

• Know that drug also can be prepared in polyvinyl chloride bags.

• Don't infuse longer than 15 minutes; doing so increases risk of adverse reactions.

Keep patient supine during administration.

Adverse reactions

CNS: dizziness, drowsiness, rigors

CV: hypotension

GI: nausea, vomiting

Metabolic: hypocalcemia

Respiratory: dyspnea, sneezing

Skin: flushing, rash, urticaria, erythema multiforme

Other: chills, warm sensation, hiccups, allergic reactions


Drug-drug. Antihypertensives: increased risk of hypotension

Drug-diagnostic tests. Calcium: decreased level

Patient monitoring

• Monitor blood pressure every 5 minutes during infusion and immediately after infusion as clinically indicated.

• Assess for severe nausea and vomiting.

• Monitor fluid intake and output.

• Monitor blood calcium level. Give calcium supplements as ordered.

Patient teaching

• Emphasize importance of remaining supine during drug administration to prevent hypotension.

• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.

• Advise patient to minimize GI upset by eating small, frequent servings of food and drinking plenty of fluids.

• Provide dietary counseling. Refer patient to dietitian if adverse GI effects significantly limit food intake.

• Inform patient that sneezing is a normal effect of drug.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and tests mentioned above.


/am·i·fos·tine/ (am″ĭ-fos´tēn) a chemoprotectant used to prevent renal toxicity in cisplatin chemotherapy.


a cytoprotective agent for cisplatin.
indications This drug is used to reduce renal toxicity when cisplatin is given to treat ovarian carcinoma. It also reduces xerostomia in radiotherapy for head and neck cancer.
contraindications Known hypersensitivity to mannitol or aminothiol, hypotension, dehydration, and lactation prohibit the use of this drug.
adverse effects Dizziness, somnolence, sneezing, flushing, hiccups, hypocalcemia, rash, and chills are among this drug's side effects. Common side effects include hypotension, nausea, and vomiting.


A drug used to reduce the side effects of anticancer treatments, especially the dangers of infection and of damage to the kidneys. A brand name is Ethyol.
References in periodicals archive ?
Amifostine reduces the seminiferous epithelium damage in doxorubicin-treated prepubertal rats without improving the fertility status.
Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats.
Among radioprotective agents, amifostine has been evaluated as a powerful radio protector, but this drug is only effective at high doses, which is close to the toxic level (i.
It's API products include Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budensonide and Carvedilol.
For example co-administration of captoperil to reduce the DOX-induced nephrotoxicity and amifostine to attenuate the DOX-induced cytotoxicity in the semniferous epithelial have been demonstrated (Mansour et al.
7] The cytoprotective agent amifostine combined with careful treatment planning, including intensity-modulated radiation therapy (IMRT), can minimize radiation-induced xerostomia; however, this drug is associated with unfavorable side effects and IMRT is not available in many oncology centers.
Demiral AN, Yerebakan O, Simsir V, Alpsoy E: Amifostine induced toxic epidermal necrolysis during radiotherapy: a case report.
Cimetidine 300 mg Prevent upper GI bleeding in (Tagamet[R]) critically-ill patients; OTC to relieve heartburn or acid indigestion Amifostine 500 mg Protective agent for selective cells (Ethyol[R]) to reduce toxicities associated with radiation and chemotherapy, particularly xerostomia Cisplatin 69-71 mg Antineoplastic agent used to treat a (Platinol[R]-AQ) variety of cancers, including head and neck cancers Magnesium 1.